000			02211 a2200577 4500
005			20250515134009.0
264		0	_c20081124
008			200811s 0 0 eng d
022			_a0009-2797
024	7		_a10.1016/j.cbi.2008.07.011 _2doi
040			_aNLM _beng _cNLM
100	1		_aGavelová, Martina
245	0	0	_aReduction of doxorubicin and oracin and induction of carbonyl reductase in human breast carcinoma MCF-7 cells. _h[electronic resource]
260			_bChemico-biological interactions _cOct 2008
300			_a9-18 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_a3-Hydroxysteroid Dehydrogenases _xantagonists & inhibitors
650	0	4	_aAlcohol Oxidoreductases _xantagonists & inhibitors
650	0	4	_aAldehyde Reductase
650	0	4	_aAldo-Keto Reductase Family 1 Member C3
650	0	4	_aAldo-Keto Reductases
650	0	4	_aBiotransformation _xdrug effects
650	0	4	_aBlotting, Western
650	0	4	_aBreast Neoplasms _xenzymology
650	0	4	_aCell Line, Tumor
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDoxorubicin _xanalogs & derivatives
650	0	4	_aEnzyme Induction _xdrug effects
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aEthanolamines _xchemistry
650	0	4	_aGene Expression Regulation, Neoplastic _xdrug effects
650	0	4	_aHumans
650	0	4	_aHydroxyprostaglandin Dehydrogenases _xantagonists & inhibitors
650	0	4	_aIsoquinolines _xchemistry
650	0	4	_aKinetics
650	0	4	_aMethacrylates _xpharmacology
650	0	4	_aOxidation-Reduction _xdrug effects
650	0	4	_aPhenylpropionates _xpharmacology
650	0	4	_aQuercetin _xanalogs & derivatives
650	0	4	_aRNA, Messenger _xgenetics
650	0	4	_aSubcellular Fractions _xdrug effects
700	1		_aHladíková, Jana
700	1		_aVildová, Lenka
700	1		_aNovotná, Romana
700	1		_aVondrácek, Jan
700	1		_aKrcmár, Pavel
700	1		_aMachala, Miroslav
700	1		_aSkálová, Lenka
773	0		_tChemico-biological interactions _gvol. 176 _gno. 1 _gp. 9-18
856	4	0	_uhttps://doi.org/10.1016/j.cbi.2008.07.011 _zAvailable from publisher's website
999			_c18225837 _d18225837